Owlet

OWLT

Market cap $327M

OWLT's fourth-quarter results are likely to reflect subscription growth, FDA-backed differentiation and revenue gains, even as tariff pressures weigh on margins.

LEHI, Utah--(BUSINESS WIRE)---- $owlt #babymonitor--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced it has selected Hannah Cranston Media (HCM) as its public relations agency of record (AOR). Following a competitive review, Owlet selected HCM for its expertise in health tech, wellness, and consumer innovation, and its demonstrated ability to position mission-driven brands at the center of cultural and industry conversations. Having monitored more than 2.5 m.

LEHI, Utah--(BUSINESS WIRE)---- $owlt #babymonitor--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, plans to announce fourth quarter and full year 2025 financial results after market close on Thursday, March 5, 2026. Owlet's President and Chief Executive Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:30 p.m. ET the same day to discuss these results and provide a business update. Participants may access the cal.

For the quarter ended December 31, 2025, the fund returned 3.77% (Class I shares at NAV), outperforming the Russell 2000 Growth Index return of 1.22%. Lumentum's stock strength in Q4 2025 was driven by a clean earnings beat and accelerating momentum in AI-related optical demand. Stride's common stock declined -56% for the quarter, dropping significantly after the earnings release, even as the company beat EPS and revenue expectations.

LEHI, Utah--(BUSINESS WIRE)---- $owlt #babymonitor--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced a new strategic partnership with PromptCare, a leading national respiratory services and durable medical equipment (DME) provider specializing in adult and pediatric care. The partnership expands Owlet's clinical and DME footprint across key U.S. regions and supports broader access to the Company's FDA-cleared, prescription pulse oximeter, BabySat, through es.

Explore the exciting world of Owlet (OWLT +4.38%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!

OWLT joins three stocks that cleared screens for strong efficiency ratios, from turnover to margins, pointing to healthier operations for 2026.

LEHI, Utah--(BUSINESS WIRE)---- $owlt #AI--Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced a strategic partnership with webAI, a leading private AI platform, to accelerate the development of secure, personalized, and data-driven intelligence across the Owlet product ecosystem. The partnership represents a foundational step in Owlet's long-term AI strategy, focused on leveraging the Company's proprietary infant health and sleep data to deliver tailo.

OWLT is deepening healthcare partnerships to expand adoption beyond consumers, starting with hospital-prescribed monitoring and broader clinical use cases.

Remote and continuous patient monitoring is moving from a niche capability to a core pillar of modern healthcare, driven by aging populations, staffing shortages, and a push toward data-driven care both inside hospitals and at home. Against this backdrop, Owlet, Inc. OWLT and Masimo Corporation MASI represent two very different ways to invest in the same secular trend.